Home » Topics » Science » New compound

New compound
RSS

HA-344 shows promise for treating cutaneous metastatic melanoma

Sep. 10, 2021

Novel virulence factor LasB inhibitors for the treatment of P. aeruginosa infections

Sep. 10, 2021

Discovery of novel antibiotic class of tethered macrocyclic peptides

Sep. 10, 2021

NIH develops PET radioligands targeting CSF-1R for neuroinflammation

Sep. 9, 2021

GABA-A alpha5 PAM RO-7015738 presented for neurological disorders

Sep. 9, 2021

[44Sc]Sc-B28110 shows preclinical promise as a radiotracer for the imaging of prostate cancer

Sep. 8, 2021

Discovery of novel new anti-cryptosporidial lead, SLU-2633

Sep. 7, 2021

IRF5 inhibition suppresses lupus-like disease in mice

Sep. 6, 2021

HEC-866, a novel pirfenidone analogue with improved therapeutic efficacy in models of IPF

Sep. 6, 2021

QGC-606 prevents LV dysfunction in mice post-MI

Sep. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...